Proshares Ultra Nasd BiotechBIBETF
13F holders, Q2 2024 (June 30)24holders +3
7new positions
4sold out
1famous investor
$59.26avg. 13F price*
At the end of Q2 2024, 24 institutions reported holding Proshares Ultra Nasd Biotech (BIB) in their 13F filings, up 3 from Q1 2024. 7 opened new positions and 4 sold out. The largest holders were Susquehanna International Group, LLP ($954K), Toth Financial Advisory Corp. ($750K) and Tower Research Capital LLC (TRC) ($731K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Proshares Ultra Nasd Biotech
- CUSIP
- 74347R214
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.5M |
| Exits | 4 | $439K |
All 13F filers, Q1 2024 → Q2 2024: 54,321 shares bought and 23,651 shares sold, net +30,670 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Susquehanna International Group, LLP | 0.00% | New | 16,098 | $954K |
| Toth Financial Advisory Corp. | 0.10% | Reduce -51.5% | 12,656 | $750K |
| Tower Research Capital LLC (TRC) | 0.01% | Add +123300.0% | 12,340 | $731K |
| IMC-Chicago, LLC | 0.02% | New | 11,849 | $702K |
| Capital Investment Advisors, LLC | 0.01% | Reduce -3.2% | 10,545 | $625K |
| Chase Investment Counsel Corp. | 0.22% | Reduce -12.6% | 10,535 | $624K |
| Westwood Wealth Management | 0.23% | No change | 10,000 | $593K |
| Citadel Advisors | 0.00% | New | 8,972 | $532K |
| Cassaday & Co Wealth Management LLC | 0.01% | No change | 4,499 | $267K |
| Jane Street Group, LLC | 0.00% | New | 4,429 | $262K |
| Palumbo Wealth Management LLC | 0.10% | No change | 4,000 | $237K |
| Morgan Stanley | 0.00% | Reduce -28.1% | 707 | $42K |
| Simplex Trading, LLC | 0.00% | Add +5.9% | 553 | $32K |
| US Bancorp \de | 0.00% | No change | 500 | $30K |
| Osaic Holdings, Inc. | 0.00% | New | 300 | $18K |
| UBS Group AG | 0.00% | Add +4.2% | 248 | $15K |
| Harel Insurance Investments & Financial Services Ltd. | 0.00% | No change | 198 | $12K |
| Hantz Financial Services, Inc. | 0.00% | No change | 178 | $11K |
| Cypress Capital, LLC | 0.00% | New | 173 | $10K |
| Signaturefd, LLC | 0.00% | No change | 150 | $9K |
| Ashton Thomas Private Wealth, LLC | 0.00% | New | 129 | $8K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 60 | $4K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -88.7% | 53 | $3K |
| Wells Fargo & Company | 0.00% | No change | 1 | $41 |
"% of holder's portfolio" is BIB's weight in each manager's 13F, not the share of Proshares Ultra Nasd Biotech the manager owns.